Skip to main content
. 2011 Jan 1;5(1):37–45.

Figure 5.

Figure 5

The response to cisplatin in high grade serous FTCA orthotopic tumors (P3). (A) Schematic of the time-course of cisplatin treatment in mice injected with P3 tumors. (B) Tumor burden in the peritoneal cavity of mice treated with vehicle or cisplatin. (C) Representative sections from vehicle and cisplatin-treated tumors obtained 24 h after the final dose and stained for pH2Ax and mib-1. (D) Graph representing percentage of cells expressing pH2AX and mib-1 in control and cisplatin-treated tumors.